Drug comparisons
Canagliflozin vs Acarbose
Compare Canagliflozin (Invokana) vs Acarbose (Precose) for type 2 diabetes: mechanisms, CV/renal benefits, side effects, and which may be preferable based on patient factors.
No comparison dimensions are available for this page.
Clinical context
This comparison typically arises for type 2 diabetes patients considering an SGLT2 inhibitor versus an older alpha-glucosidase inhibitor, especially with cardiovascular or renal risk.
Bottom line
Canagliflozin usually offers broader benefits than Acarbose for most adults with type 2 diabetes, particularly those with heart or kidney disease, though individual factors decide suitability.
All medication comparisons